Johnson & Johnson said on Thursday it has asked U.S. health regulators to authorize its single-dose COVID-19 vaccine for ...

The top U.S. Food and Drug Administration official on Tuesday confirmed AstraZeneca Plc's U.S. COVID-19 vaccine trial is on ...

The once-daily oral drug, a SARS-CoV-2 main protease inhibitor developed by Shionogi, is registered in Japan and Singapore ...

There's still a lot of confusion around the best time to take a COVID test and where to get them. Here, experts share their ...

New federal guidance surrounding COVID vaccine authorization could make it more difficult for many people to be inoculated against the circulating — and, now, seasonally spiking — coronavirus. Under ...

Moderna lowered the top end of its 2025 revenue forecast by $200 million on Thursday, citing weaker-than-expected sales of ...

The U.S. Food and Drug Administration is expected to announce within the next 48 hours that it is authorizing COVID-19 vaccine booster shots for some people who are immunocompromised, according to a ...

The U.S. Food and Drug Administration approved 2025-26 COVID-19 vaccines for anyone age 65 and older and any person 6 months and older who has at least one underlying health condition that increases ...

President Donald Trump’s physician, Dr. Sean P. Barbabella, announced that after conducting a battery of tests, he found that ...

Food and Drug Administration officials plan to present data they claim links the Covid vaccine to 25 deaths in children at what’s expected to be a closely watched vaccine advisory committee next week, ...

The FDA narrowed approval of the new COVID-19 vaccines. The U.S. Food and Drug Administration in August narrowed approval of the new, updated COVID-19 vaccines only to people who are over 65, or ...

The intravenous formulation of fosfomycin has a novel mechanism of action an no known cross-resistance to other antibiotic ...